Medical societies release coordinated vaccine recommendations amid ongoing debates over federal advice

Leading U.S. medical groups have published new coordinated guidance for flu, Covid-19 and RSV vaccinations, emphasising evidence-based recommendations as federal advice remains unsettled post administrative shifts and political controversies.

Leading U.S. medical societies have published a co-ordinated set of autumn recommendations for flu, Covid-19 and RSV vaccinations, releasing not just the advice itself but the evidence behind it in an attempt to steady clinicians and families after months of upheaval in federal vaccine policy. The package was issued on 2 September 2026, with the supporting material presented as a public-facing alternative to a federal process that doctors say has become unsettled. (apnews.com)

Rather than offering a single catch-all schedule, the groups divided the work by specialty and patient population. The American Academy of Pediatrics issued paediatric recommendations, the American Academy of Family Physicians set out guidance for family doctors, and the Infectious Diseases Society of America published separate advice for people with weakened immune systems. The American College of Clinical Pharmacy, highlighting the releases on 3 September, said the framework also matters for pharmacists responsible for vaccine delivery, patient education and putting immunisation plans into practice. (aafp.org)

At the centre of the effort is the Vaccine Integrity Project, based at the University of Minnesota, which said it reviewed 299 eligible studies published mainly between August 2025 and June 2026. According to the project’s executive summary, influenza, Covid-19 and RSV still account for substantial illness in the United States, with the greatest burden falling on older adults, infants, pregnant women, people with underlying conditions and those who are immunocompromised. The review concluded that currently used immunisations continue to provide meaningful protection against severe disease, hospitalisation and death, and that comparative studies did not reveal new safety concerns. (vaxintegrity.cidrap.umn.edu)

The medical societies made little attempt to hide why they were stepping in. AP reported that the groups wanted to reduce confusion caused by the Trump administration’s changing advice, while Sandra Fryhofer of the American Medical Association said: “There’s been a lot of confusion and chaos regarding vaccine recommendations.” The Vaccine Integrity Project said the usual federal advisory route was thrown off course after the Department of Health and Human Services dismissed the CDC’s vaccine advisers last year and replaced them, adding that, despite a successful court challenge in March, an expert-led advisory committee had still not been restored. (apnews.com)

The figures the societies are using to justify the push are more detailed than the political argument around them. The Vaccine Integrity Project said updated Covid-19 vaccination during the 2025-2026 season was 53% effective against hospitalisation among adults aged 65 and older, while vaccination was associated with a 76% reduction in Covid-related emergency department visits among children aged 9 months to 4 years. For influenza, the project cited a 31% reduction in hospital admissions among older adults in one analysis and said vaccination was 48% effective against flu-related hospitalisation or emergency department visits among children aged 6 months to 17 years with underlying medical conditions. It also pointed to evidence across eight seasons showing 80% effectiveness against laboratory-confirmed flu deaths in children and adolescents. (apnews.com)

The family physicians’ guidance adds some of the clearest practical advice for surgeries and clinics. The AAFP said all adults aged 19 and older should receive a Covid-19 vaccine, with particular emphasis on people aged 65 and over, those at increased risk of severe infection, and adults who have never previously been vaccinated. It also recommended Covid-19 vaccination for all children aged 6 to 23 months, alongside a risk-based single-dose approach for children and teenagers aged 2 to 18, while stressing continued access for families who want vaccination. For pregnancy, it backed Covid-19 vaccination in any trimester and during lactation, and advised RSV vaccination between 32 and 36 weeks’ gestation during September to March. (aafp.org)

The paediatric RSV guidance is more specific still. In its new policy statement, the American Academy of Pediatrics recommended RSV immunisation for all infants younger than 8 months who are born during, or entering, their first RSV season, unless they already have documented protection because their pregnant parent was vaccinated. It also advised RSV immunisation for high-risk children aged 8 through 19 months entering a second season, saying the evidence supported expanding the criteria for which children in that age band should qualify. The broader evidence review said maternal RSV vaccination given between 32 and 36 weeks of pregnancy was 51% to 70% effective against RSV-related hospitalisation in infants, while nirsevimab cut infant emergency department consultations by 86% to 97% and reduced RSV hospitalisation by roughly 66% to 93% within six months of immunisation. (publications.aap.org)

For immunocompromised patients, the Infectious Diseases Society of America took an explicitly high-risk approach. It strongly recommended Covid-19 vaccination and annual flu vaccination for everyone with a compromised immune system aged 6 months and older, and RSV vaccination for immunocompromised adults and adolescents. The society said some patients may benefit from an additional Covid dose or from high-dose or adjuvanted flu vaccines, and warned that live-attenuated influenza vaccines should not be used in this group. It also said Covid, flu and RSV vaccines can be given at the same visit, and that where possible vaccination should be timed before a transplant, chemotherapy or another immune-suppressing treatment. Ronald Nahass, the society’s president, said: “Getting vaccinated early this fall remains one of the most effective ways to prevent severe illness.” (idsociety.org)

Taken together, the societies are trying to recreate something that used to sit more squarely inside the federal system: a visible chain from evidence review to clinical recommendation. The Vaccine Integrity Project said respiratory viruses still lead to hundreds of thousands of hospitalisations in the U.S. each year, and the AMA-backed initiative has paired the new recommendations with an online resource hub aimed at doctors, patients and carers. For clinicians facing another respiratory-virus season, the message from the specialist groups is less about politics than process: publish the evidence, show the reasoning and let families see why the advice is being given. (vaxintegrity.cidrap.umn.edu)